54 related articles for article (PubMed ID: 8970055)
1. Regression of calcinosis during diltiazem treatment in juvenile dermatomyositis.
Oliveri MB; Palermo R; Mautalen C; Hübscher O
J Rheumatol; 1996 Dec; 23(12):2152-5. PubMed ID: 8970055
[TBL] [Abstract][Full Text] [Related]
2. Bisphosphonate therapy for juvenile dermatomyositis-associated calcinosis and metaphyseal zebra lines.
Janarthanan M; Mohan M; Murali A
BMJ Case Rep; 2022 Nov; 15(11):. PubMed ID: 36343985
[No Abstract] [Full Text] [Related]
3. Subcutaneous immunoglobulin for the treatment of calcinosis associated with juvenile dermatomyositis.
Rodríguez-Lozano AL; Mata-Aguilera X; Rivas-Larrauri F; Bustamante-Ogando JC; Gutierrez-Hernandez A; Bojalil-Cabildo A; Scheffler-Mendoza S; Yamazaki-Nakashimada M
Int J Rheum Dis; 2024 Jun; 27(6):e15239. PubMed ID: 38923294
[No Abstract] [Full Text] [Related]
4. Calcinosis Biomarkers in Adult and Juvenile Dermatomyositis.
Chung MP; Richardson C; Kirakossian D; Orandi AB; Saketkoo LA; Rider LG; Schiffenbauer A; von Mühlen CA; Chung L; ;
Autoimmun Rev; 2020 Jun; 19(6):102533. PubMed ID: 32234404
[TBL] [Abstract][Full Text] [Related]
5. Dermatomyositis presenting with diffuse calcinosis.
Walsh M; Bettendorf B; Zahn C
BMJ Case Rep; 2023 Dec; 16(12):. PubMed ID: 38103899
[TBL] [Abstract][Full Text] [Related]
6. Composition of calcifications in children with juvenile dermatomyositis: association with chronic cutaneous inflammation.
Pachman LM; Veis A; Stock S; Abbott K; Vicari F; Patel P; Giczewski D; Webb C; Spevak L; Boskey AL
Arthritis Rheum; 2006 Oct; 54(10):3345-50. PubMed ID: 17009308
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of topical sodium thiosulfate for ectopic calcifications and ossifications. Results of the CATSS-O study.
Gauffenic A; Ratsimbazafy V; Ostertag A; Linglart A; Bourrat E; Leroy C; Lioté F; Latourte A; Richette P; Ea HK; Guigonis V
Semin Arthritis Rheum; 2023 Dec; 63():152306. PubMed ID: 37976811
[TBL] [Abstract][Full Text] [Related]
8. Contribution of the Interferon score in the management of an anti-NXP2 dermatomyositis patient with calcinosis successfully treated with tofacitinib.
Robert M; Gallay L; Garnier L; Pescarmona R; Hot A
Joint Bone Spine; 2023 Jul; 90(4):105532. PubMed ID: 36706944
[No Abstract] [Full Text] [Related]
9. Generalized Dystrophic Calcinosis Cutis in a Patient with Dermatomyositis.
Del Barrio-Díaz P; Mellado-Francisco G; Vera-Kellet C
J Gen Intern Med; 2022 Jan; ():. PubMed ID: 35102481
[No Abstract] [Full Text] [Related]
10. Painful palmar calcinosis in juvenile dermatomyositis.
Guliani A; Bishnoi A; Kumar S; Vignesh P; Vinay K
Lancet Rheumatol; 2020 May; 2(5):e308. PubMed ID: 38273476
[No Abstract] [Full Text] [Related]
11. Local injection of infliximab into calcinosis lesions in patients with juvenile dermatomyositis (JDM): a clinical trial.
Shiari R; Khalili M; Zeinali V; Shashaani N; Samami M; Moghaddamemami FH
Pediatr Rheumatol Online J; 2024 Jan; 22(1):2. PubMed ID: 38166943
[TBL] [Abstract][Full Text] [Related]
12. Calcinosis in Juvenile Dermatomyositis-Epidemiology, Pathogenesis, Clinical Features, and Treatment: A Systematic Review.
Gonçalves Júnior J; Shinjo SK
Curr Rheumatol Rep; 2024 Feb; 26(2):53-68. PubMed ID: 38060107
[TBL] [Abstract][Full Text] [Related]
13. Idiopathic Inflammatory Myopathies.
Balan S; Madan S
Indian J Pediatr; 2023 Nov; ():. PubMed ID: 37919486
[TBL] [Abstract][Full Text] [Related]
14. Subcutaneous calcinosis: Is it different between systemic sclerosis and dermatomyositis?
Valenzuela A; Chung L
J Scleroderma Relat Disord; 2022 Feb; 7(1):7-23. PubMed ID: 35386947
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Calcinosis in Juvenile Dermatomyositis.
Kul Cinar O; Papadopoulou C; Pilkington CA
Curr Rheumatol Rep; 2021 Feb; 23(2):13. PubMed ID: 33555459
[TBL] [Abstract][Full Text] [Related]
16. Tumoral Calcinosis as an Initial Complaint of Juvenile-Onset Amyopathic Dermatomyositis.
Doh EJ; Moon J; Shin S; Seo SH; Park HS; Yoon HS; Cho S
Ann Dermatol; 2016 Jun; 28(3):375-80. PubMed ID: 27274638
[TBL] [Abstract][Full Text] [Related]
17. Dramatic Improvement of Subcutaneous Calcinosis by Intermittent, High-Dose Etidronate plus Cimetidine in a Patient with Juvenile Dermatomyositis.
Wakabayashi T; Sasaki N; Chinen N; Suzuki Y
Case Rep Rheumatol; 2015; 2015():817592. PubMed ID: 26640735
[TBL] [Abstract][Full Text] [Related]
18. The presentation, assessment, pathogenesis, and treatment of calcinosis in juvenile dermatomyositis.
Hoeltzel MF; Oberle EJ; Robinson AB; Agarwal A; Rider LG
Curr Rheumatol Rep; 2014 Dec; 16(12):467. PubMed ID: 25366934
[TBL] [Abstract][Full Text] [Related]
19. Clinical features, pathogenesis and treatment of juvenile and adult dermatomyositis.
Robinson AB; Reed AM
Nat Rev Rheumatol; 2011 Sep; 7(11):664-75. PubMed ID: 21947177
[TBL] [Abstract][Full Text] [Related]
20. Marked improvement of calcinosis in adult dermatomyositis with etidronate therapy.
Mori H; Okada Y; Yamaoka K; Saito K; Tanaka Y
J Bone Miner Metab; 2012 Jan; 30(1):114-8. PubMed ID: 21710176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
